ドナネマブの物語:神は細部にある
Takaomi C Saido1,2, Nobuhisa Iwata3
1Laboratory for Proteolytic Neuroscience, RIKEN Center for Brain Science, Saitama, Japan.
Journal of Alzheimer's disease : JAD
|September 3, 2025
まとめ
ドーナネマブという新しいアルツハイマー病の治療法は 特定のアミロイドβペプチドを標的としています この単一クローン抗体は 早期アルツハイマー病の 精密治療法で 病気の進行を遅らせます
科学分野:
- 神経科学
- 生物化学
- 薬理学について
背景:
- アルツハイマー病 (AD) は認知症の主な原因で 世界中で何百万人もの人に影響しています
- 早期発見と治療は,ADの公衆衛生への影響管理に不可欠です.
- アミロイドベータ (Aβ) ペプチドはADの脳の主要な病理的特徴です.
研究 の 目的:
- 初期アルツハイマー病のモノクローナル抗体であるドナネマブの研究と開発をレビューする.
- ADの病原性におけるピログルタミルアミロイドβ (Aβ3pE-X) の重要性を強調する.
- ドナネマブをレカネマブのような他の治療法と比較し,治療効果について議論する.
主な方法:
- 30年以上にわたるAβ種の生化学的識別
- 特定のAβ同型を標的とする単一クローン抗体の開発.
- ドナネマブのメカニズム的特徴と治療的可能性の分析
主要な成果:
- Aβ3pE-42をADにおける主要な病理的同型体として認識する.
- ドーナネマブはピログルタミルアミロイドβ (Aβ3pE- X) ペプチドを標的とする.
- ドーナネマブの開発はAD治療における 精密医療への移行を意味しています
結論:
- ドナネマブの開発は,アミロイド仮説とADの精密医療アプローチを検証しています.
- 特定のAβ種を標的とした治療は,臨床前段階で疾患の進行を止めることができる.
- 世界的な認知症の負担に対処するには 拡張性があり 費用対効果の高い介入が必要です
関連する概念動画
Bone Marrow Sampling and Transplants
493
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
493
The Early Endosome: Endocytosis of Transferrin
3.4K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
3.4K
Drug Delivery: Parenteral Route
827
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
827
Antibody Actions
1.3K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.3K
Canonical Wnt Signaling Pathway
8.9K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.9K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K


